Fig. 4From: A European Society of Oncologic Imaging (ESOI) survey on the radiological assessment of response to oncologic treatments in clinical practiceThe charts show the perceived advantages (a) and disadvantages (b) of reporting with RECIST 1.1 criteriaBack to article page